Skip to content
etf.net

TDNA

We have not yet analyzed this fund's documents to determine what it sets out to do. This is typical for new listings awaiting their first analysis pass.NASDAQ

T. Rowe Price Biotech ETF

T. Rowe · Inception 2026-09-16 · SEC filings

$24.50−1.09 (−4.25%)

As of Sep 23, 2026, 2:21 PM EDT

History starts Sep 17, 2026.History starts Sep 17, 2026.History starts Sep 17, 2026.History starts Sep 17, 2026.History starts Sep 17, 2026.
Intraday session: down, 21 prints from 25.59 to 24.50. Range 24.50 to 25.50. Use the arrow keys to read each point.$24.80$25.20$25.6010 AM12 PM2 PM4 PM
Expense ratio
0.55%
Fund size
$10M
1Y return
—
Yield · Last 12 months
—
Volume · 30D
0M sh
NAV per share
$25.18
52W range
low $24.97high $25.68

TDNA Holdings

As of Sep 20, 2026, 7:24 AM
Asset class
Stocks
Holdings
—
Top-10 weight
27%
Largest holding
ARGX5.5%

Geography

  • United States89.08%
  • Netherlands5.63%
  • Ireland1.84%
  • United Kingdom1.59%
  • Denmark0.76%
  • Canada0.74%
  • France0.36%
The fund’s holdings, weight-ordered — page 1 of 6.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001ARGXARGENX SE ADR ADR5.54%567$565K68
002KYMRKYMERA THERAPEUTICS INC COMMON STOCK USD.00014.22%3,629$430K103
003INSMINSMED INC COMMON STOCK USD.012.93%2,403$298K183
004RVMDREVOLUTION MEDICINES INC COMMON STOCK2.29%1,185$233K169
005VRTXVERTEX PHARMACEUTICALS INC COMMON STOCK USD.012.20%433$224K417
006DNTHDIANTHUS THERAPEUTICS INC COMMON STOCK USD.0012.17%2,182$221K81
007PRAXPRAXIS PRECISION MEDICINES I COMMON STOCK USD.00012.11%691$215K103
008CYTKCYTOKINETICS INC COMMON STOCK USD.0012.02%2,936$205K139
009ARWRARROWHEAD PHARMACEUTICALS IN COMMON STOCK USD.0012.01%3,017$204K151
010UTHRUNITED THERAPEUTICS CORP COMMON STOCK USD.011.99%407$202K271
011ALNYALNYLAM PHARMACEUTICALS INC COMMON STOCK USD.011.99%824$202K258
012NTRANATERA INC COMMON STOCK1.96%546$200K223
013BBIOBRIDGEBIO PHARMA INC COMMON STOCK1.92%2,910$196K119
014RYTMRHYTHM PHARMACEUTICALS INC COMMON STOCK1.90%1,958$194K81
015PCVXVAXCYTE INC COMMON STOCK USD.0011.89%3,194$193K106

Showing 1–15 of 86 holdings

TDNA Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

TDNA$10,038
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$10,167
Sep 17, 2026 to Sep 22, 2026. TDNA $10,038. SPY $10,167. Use the arrow keys to read each point.$9,766$9,982$10,198Sep 17Sep 18Sep 22

History from Sep 17, 2026 – Sep 22, 2026

Returns run to the last market close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for TDNA. Periods over one year show the average yearly return.
PeriodTDNA
Year to dateFund launched this year—
1 monthFund is under 1 month old—
3 monthsFund is under 3 months old—
1 yearFund is under 1 year old—
3 yearsFund is under 3 years old—per year
5 yearsFund is under 5 years old—per year
10 yearsFund is under 10 years old—per year

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for TDNA
YearReturn barTDNA
2026 YTD+0.4%

History from Sep 17, 2026

TDNA in the news

TDNA Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
—Last 12 months
Payout per share
—Last 12 months

Listed Sep 2026. No distributions yet.

TDNA Risk

How much the fund’s monthly returns vary, scaled to a year.
—
Launched Sep 2026; fills in after 12 months
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
—
Launched Sep 2026; fills in after 12 months
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
—
Launched Sep 2026; fills in after 12 months
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.00
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

TDNA Cost

Expense Ratio
0.55%